The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(3-((5-Chloro-2-(4-(3-(4-fluorinebenzenesulfonicamide)methyl)phenylamino)-4-pyrimidinyl)amino)phenyl)acrylamide ID: ALA4086899
PubChem CID: 137643176
Max Phase: Preclinical
Molecular Formula: C26H22ClFN6O3S
Molecular Weight: 553.02
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(NS(=O)(=O)c4ccc(F)cc4)c(C)c3)ncc2Cl)c1
Standard InChI: InChI=1S/C26H22ClFN6O3S/c1-3-24(35)30-18-5-4-6-19(14-18)31-25-22(27)15-29-26(33-25)32-20-9-12-23(16(2)13-20)34-38(36,37)21-10-7-17(28)8-11-21/h3-15,34H,1H2,2H3,(H,30,35)(H2,29,31,32,33)
Standard InChI Key: BFBFWHVADNJHTJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
38 41 0 0 0 0 0 0 0 0999 V2000
11.9607 -6.8553 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.7779 -6.8553 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
12.3693 -6.1476 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.1962 -1.9521 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.1951 -2.7717 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9031 -3.1806 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.6128 -2.7712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6100 -1.9485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9014 -1.5433 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3212 -3.1787 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.3224 -3.9959 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4871 -3.1797 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.4864 -3.9969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7783 -4.4034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7773 -5.2198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4852 -5.6298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1956 -5.2174 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1931 -4.4023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6141 -4.4040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6150 -5.2205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3239 -5.6288 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0333 -5.2147 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0289 -4.3996 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7431 -5.6196 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.7472 -6.4368 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4570 -6.8418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0416 -6.8490 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.4612 -7.6590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4856 -6.4470 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.7786 -7.6732 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0690 -8.0794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0691 -8.8958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7776 -9.3048 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4874 -8.8915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4838 -8.0764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3161 -1.5373 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
14.9044 -5.6240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7791 -10.1220 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
7 10 1 0
10 11 1 0
5 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
11 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 11 1 0
22 24 1 0
24 25 1 0
25 26 1 0
25 27 2 0
26 28 2 0
16 29 1 0
29 2 1 0
2 30 1 0
30 31 2 0
31 32 1 0
32 33 2 0
33 34 1 0
34 35 2 0
35 30 1 0
8 36 1 0
17 37 1 0
33 38 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 553.02Molecular Weight (Monoisotopic): 552.1147AlogP: 5.99#Rotatable Bonds: 9Polar Surface Area: 125.11Molecular Species: NEUTRALHBA: 7HBD: 4#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski): 2CX Acidic pKa: 8.43CX Basic pKa: 2.94CX LogP: 5.94CX LogD: 5.91Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.19Np Likeness Score: -1.88
References 1. Liu H, Qu M, Xu L, Han X, Wang C, Shu X, Yao J, Liu K, Peng J, Li Y, Ma X.. (2017) Design and synthesis of sulfonamide-substituted diphenylpyrimidines (SFA-DPPYs) as potent Bruton's tyrosine kinase (BTK) inhibitors with improved activity toward B-cell lymphoblastic leukemia., 135 [PMID:28432946 ] [10.1016/j.ejmech.2017.04.037 ]